DISABILITY AND HANDICAP IN DERMATOLOGY
1996; Wiley; Volume: 35; Issue: 5 Linguagem: Inglês
10.1111/j.1365-4362.1996.tb03628.x
ISSN1365-4632
Autores Tópico(s)Autoimmune and Inflammatory Disorders
ResumoInternational Journal of DermatologyVolume 35, Issue 5 p. 305-311 DISABILITY AND HANDICAP IN DERMATOLOGY ANDREW Y. FINLAY M.D., FRCP, Corresponding Author ANDREW Y. FINLAY M.D., FRCP Departments of Dermatology, University of Wales College of Medicine, Cardiff, Wales, and The Churchill Hospital, Oxford, England.Address for correspondence: Dr. A. Y. Finlay, FRCP, Department of Dermatology, University of Wales College of Medicine, Health Park, Cardiff, CF4 4XN, Wales.Search for more papers by this authorTERENCE J. RYAN D. M., FRCP, TERENCE J. RYAN D. M., FRCP Departments of Dermatology, University of Wales College of Medicine, Cardiff, Wales, and The Churchill Hospital, Oxford, England.Search for more papers by this author ANDREW Y. FINLAY M.D., FRCP, Corresponding Author ANDREW Y. FINLAY M.D., FRCP Departments of Dermatology, University of Wales College of Medicine, Cardiff, Wales, and The Churchill Hospital, Oxford, England.Address for correspondence: Dr. A. Y. Finlay, FRCP, Department of Dermatology, University of Wales College of Medicine, Health Park, Cardiff, CF4 4XN, Wales.Search for more papers by this authorTERENCE J. RYAN D. M., FRCP, TERENCE J. RYAN D. M., FRCP Departments of Dermatology, University of Wales College of Medicine, Cardiff, Wales, and The Churchill Hospital, Oxford, England.Search for more papers by this author First published: May 1996 https://doi.org/10.1111/j.1365-4362.1996.tb03628.xCitations: 48AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Ryan TJ. Healthy skin for al 829–835. 2 International classification of impairments, disabilities and handicaps. Geneva : World Health Organization, 1980. 3 Martial (c.40–c.104 AD). Epigrammatica, Book 6, no. 70. In: A Partington, ed. The Oxford dictionary of quotations. Oxford : Oxford University Press, 1992: 449. 4 Brayboy ME. The sociological effects on an individual with Hansen's disease. The Star 1984; 43: 4–14. 5 Reddy NBB, Satpathy SK, Krishnan SAR, Srinivasan T. Social aspects of leprosy: a case study in Zaria, Northern Nigeria. Lepr Rev 1985; 56: 23–25. 6 Sulzberger MB, Zaidens SH. Psychogenic factors in dermatologic disorders. Med Clin North Am 1948; 32: 669–685. 7 Whitmore CW. Cutaneous impairment, disability and rehabilitation. Cutis 1970; 6: 989–992. 8 Robinson HM. Measurement of impairment and disability in dermatology. Arch Dermatol 1973; 108: 207–209. 9 Samitz MH. Assessment of cutaneous impairment and disability. In: HI Maibach, GA Gellin, eds. Occupational and industrial dermatology. Ch. 19. Chicago , IL : Yearbook Medical Publishers, 1982: 165–169. 10 Committee on rating of mental and physical impairment. The skin. JAMA 1970; 211: 106–112. 11 Molin L. Psoriasis. Acta Derm Venereol Stockh 1973; (Suppl 72): 1–125. 12 Jowett S, Ryan TJ. Skin disease and handicap: an analysis of the impact of skin conditions. Soc Sci Med 1985; 20: 425–429. 13 Ryan TJ. Disability in dermatology. Br J Hosp Med 1991; 46: 33–36. 14 Russell PS. Dermatology in the Oregon Plan with implications for health care plans in other states. Arch Dermatol 1994; 130: 709–712. 15 Maynard A. Requirements for health care purchaser. In: SR Walker, RM Rosser, eds. Quality of life assessment: key issues in the 1990s. London : Kluwer Academic Publishers, 1993: 413–426. 16 Shorvon SD, Hart YM, Sander JWAS, Andel F van. The management of epilepsy in developing countries: an "iceberg" manual. International congress and symposium series. Vol. 175. London : Royal Society of Medicine Services, 1991: 1–66. 17 Berry JW. Cultural and ethnic factors in health. Cambridge handbook of psychology, health and medicine. Cambridge , UK : Cambridge University Press, 1995. 18 Frank AO. The family and disability-some reflections on culture: discussion paper. J R Soc Med 1989; 82: 666–668. 19 Ingram JT. The significance and management of psoriasis. BMJ 1954; 2: 823–828. 20 Stankler I. The effect of psoriasis on the sufferer. Clin Exp Dermatol 1981; 6: 303–306. 21 Jobling RG. Psoriasis-a preliminary questionnaire study of sufferers' subjective experience. Clin Exp Dermatol 1976; 1: 233–236. 22 Ramsay B, O'Reagan M. A survey of the social and psychological effects of psoriasis. Br J Dermatol 1988; 118: 195–201. 23 Ginsburg IH, Link BG. Feelings of stigmatization in patients with psoriasis. J Am Acad Dermatol 1989; 20: 53–63. 24 Jobling R. Psoriasis and its treatment in psycho-social perspective. Rev Contemp Pharmacother 1992; 3: 339–345. 25 Logan RA. Self help groups for patients with chronic-skin diseases. Br J Dermatol 1988; 118: 505–508. 26 Price ML, Mottahedin I, Mayo PR. Can psychotherapy help patients with psoriasis Clin Exp Dermatol 1991; 16: 114–117. 27 Lowe JG. The stigma of acne. Br J Hosp Med 1993; 49: 809–812. 28 Cunliffe WJ. Acne and unemployment. Br J Dermatol 1986; 115: 386. 29 Lawson V, Lewis-Jones MS, Reid P, et al. Family impact of childhood atopic eczema. Br J Dermatol 1995; 133 (Suppl45): 19. 30 Long CC, Funnell CM, Collard R, Finlay AY. What do members of the National Eczema Society really want Clin Exp Dermatol 1993; 18: 516–522. 31 Phillips T, Stanton B, Provan A, Lew R. A study of the impact of leg ulcers on quality of life: financial, social, and psychologic implications. J Am Acad Dermatol 1993; 31: 49–53. 32 Franks PJ, Moffatt CJ, Connolly M, et al. Community leg ulcer clinics: effects on quality of life. Phlebology 1994; 9: 83–86. 33 Lanigan S. The stigma of port-wine stains. Br J Hosp Med 1991; 45: 274–276. 34 Lubeck DP, Patrick DL, McNulty P, et al. Quality of life of persons with onychomycosis. Qual Life Res 1993; 2: 341–348. 35 Simpson NB. Social and economic aspects of acne and the cost-effectiveness of isotretinoin. J Dermatol Treat 1993; 4 (Suppl 2): S6–S9. 36 Mallon E, Newton JN, Klassen A, et al. Standard patient-assessed quality of life instruments can be used to measure the benefits of acne treatment. Br J Dermatol 1995; 133(Suppl45): 35–36. 37 Shuster S. A misdiagnosed case of Cinderella syndrome. Dermatol Int 1994; 3: 6. 38 Finlay AY, Khan GK, Luscombe DK, Salek MS. Validation of Sickness Impact Profile and Psoriasis Disability Index in psoriasis. Br J Dermatol 1990; 123: 751–756. 39 Bergner M, Bobbit RA, Carter WB, et al. The Sickness Impact Profile: development and final revision of a health status measure. Med Care 1981; 19: 787–805. 40 Salek MS, Finlay AY, Luscombe DK, et al. Cyclosporin greatly improves the quality of life of adults with severe atopic dermatitis. Br J Dermatol 1993; 129: 422–430. 41 Blackford S, Roberts DL, Salek MS, Finlay AY. Basal cell carcinomas and their treatment cause little handicap-the reason for delayed presentation J Dermatol Treat 1994; 5: 248. 42 Ware JE. Measuring patient's views: the optimum outcome measurement. BMJ 1993; 306: 1429–1430. 43 Root S, Kent G, Al-Abadie MSK. The relationship between disease severity, disability and psychological distress in patients undergoing PUVA treatment for psoriasis. Dermatology 1994; 189: 234–237. 44 Fries JF, Spitz PW, Young DY. The dimensions of health outcomes: the health assessment questionnaire, disability and pain scales. J Rheumatol 1982; 9: 789–793. 45 Ryan TJ. The confident nude or whither dermatology. Dermatol Practice 1987; 5: 8–18. 46 Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI): a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19: 210–216. 47 Finlay AY. Measures of the effect of adult severe atopic eczema on quality of life. J Eur Acad Dermatol Venereol. (In press). 48 Blackford S, Roberts DL, Finlay AY. What is the impact on quality of life of the skin manifestations of Behçet's syndrome: Br J Dermatol 1995; 133(Suppl 45): 35–36. 49 Kurwa H, Finlay AY. Dermatology inpatient admission greatly improves life quality. Br J Dermatol 1995; 133: 575–578. 50 Lewis-Jones MS, Finlay AY. The Children's Dermatology Life Quality Index (CDLQt): initial validation and practical use. Br J Dermatol 1995; 132: 942–949. 51 Finlay AY, Kelly SE. Psoriasis-an index of disability. Clin Exp Dermatol 1987; 12: 8–11. 52 Kent G, Al-Abadie M. The Psoriasis Disability Index- further analyses. Clin Exp Dermatol 1993; 18: 414–416. 53 Finlay AY, Coles EC. The effect of severe psoriasis on the quality of life of 369 patients. Br J Dermatol 1995; 132: 236–244. 54 McHenry PM, Doherty VR. Psoriasis: an audit of patients' views on the disease and its treatment. Br J Dermatol 1992; 127: 13–17. 55 Motley RJ, Finlay AY. Practical use of a disability index in the routine management of acne. Clin Exp Dermatol 1992; 17: 1–3. 56 Motley RJ, Finlay AY. How much disability is caused by acne Clin Exp Dermatol 1989; 14: 194–198. 57 Layton AM. Psychological assessment of skin disease. Interfaces Dermatol 1994; 1: 9–11. 58 Eun HC, Finlay AY. Measurement of atopic dermatitis disability. Ann Dermatol 1990; 2: 9–12. 59 Katsambas A. Quality of life in dermatology and the EADV. J Eur Acad Dermatol Venereol 1994; 3: 211–214. 60 Kaufman A, Mariam SGM, Neville J. The social dimension of leprosy. London : International Federation of Anti-Leprosy Associations, 1982: 110. Citing Literature Volume35, Issue5May 1996Pages 305-311 ReferencesRelatedInformation
Referência(s)